| Old Articles: <Older 22441-22450 Newer> |
|---|
 |
The Motley Fool
April 20, 2007 |
Tough Times in Puerto Rico: Fool by Numbers The Puerto Rican banking company Popular released first-quarter 2007 earnings: Income Statement Highlights... Ratio Checkup... Balance Sheet Highlights...   |
The Motley Fool
April 20, 2007
Emil Lee |
Time To Capitalize on Capital One? Shares of the credit card company trade at a compelling valuation. |
The Motley Fool
April 20, 2007
Alyce Lomax |
Gold Rush at Google? Search and ye shall find reasons to be bearish about Google. The search giant's first quarter was, to put it lightly, impressive. |
The Motley Fool
April 20, 2007 |
Tempur-Pedic Pillow R&D Pays Off: Fool by Numbers The mattress maker released first-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
April 20, 2007
Seth Jayson |
The Hunted Becomes the Hunter If Foot Locker can hook Genesco, get rid of the duplicate administration, and find a few synergies, it may turn out to be quite a catch for investors. |
The Motley Fool
April 20, 2007
Ryan Fuhrmann |
Diagnosing Quest Diagnostics Quest should recover from a recent, painful contract loss. Shares trade for a reasonable 17.5 times earnings, and even lower multiple of free cash flow. |
The Motley Fool
April 20, 2007
Emil Lee |
Capital One's Credit Hassles: Fool by Numbers The financial firm released first-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... |
The Motley Fool
April 20, 2007 |
Cerner Solid: Fool by Numbers The health-care IT provider released first-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
April 20, 2007
Tim Beyers |
Who's Buying Now? Sometimes insiders are buying for all the right reasons. Who's at it this week? California Coastal Comm... Consolidated Tomoka Land... dELiA*s... General Electric... etc. |
The Motley Fool
April 20, 2007
Ryan Fuhrmann |
Discerning Pfizer's Pfuture The company is undergoing a transformation, but that doesn't mean it isn't worth a look from investors. |
| <Older 22441-22450 Newer> Return to current articles. |
